Cancer

Providence researchers awarded funding from National Cancer Institute to study “Bugs as Drugs.”

Getting regular health screenings is critical for early diagnosis and treatment even during a pandemic.

Maintaining gut heath is important for overall well-being as well as colon cancer prevention.

Providence Cancer Institute’s Rectal Cancer Program among the first 25 in the nation to earn accreditation from the National Accreditation Program for Rectal Cancer.

Providence Cancer Institute to offer a new phase I/II study of a first-in-class photoimmunotherapy for solid tumors that overexpress the epidermal growth factor receptor protein.

Peter Chung, an energetic 42-year-old, never imagined he would be dealing with a cancer diagnosis at such a young age.

Providence's Dr. Abbass uses robotics to perform surgeries like the Whipple procedure to help pancreatic cancer patients get back to life. Learn more.

Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, will join oncology professionals around the world for the 2021 ASCO Annual Virtual Conference.

New technology and neurosurgery expertise available 24/7

Immunology leader Dr. Walter Urba talks about his healthcare journey and how Providence is defining the future of personalized care.

Providence Cancer Institute to offer phase II clinical trial of neoadjuvant chemotherapy plus immunotherapy for patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Providence's Amy Compton-Phillips breaks down how genomics is helping to chart the future of personalized care. Learn more.

Low-dose CT screening offers reassurance to people at high risk for the disease.

Learn how Providence’s partnership with City of Hope helped a patient reduce his commute and spend more time doing what he loves.

A phase II, investigator-initiated clinical trial at Providence Cancer Institute aims to improve survival for patients with triple-negative breast cancer. The trial is available only at Providence.

With funding from the Kuni Foundation, the Center for Outcomes Research & Education (CORE) will investigate disparities in breast cancer screening rates.

Anton J. Bilchik, MD, PhD at Providence Saint John’s explains why timely colorectal cancer screening is important.

When a woman discovers she has ovarian, uterine or another gynecologic cancer, she needs every source of help to heal. Providence Holy Cross Medical Center and City of Hope offer comprehensive care.

A dietitian and a physical therapist share their experiences in helping patients finish cancer. Learn more.